Finnrick - Ensuring a Safer and More Transparent Supply Chain

Free peptides test: now with paid endotoxins contamination option

Anlv Biotechnology

Anlv Biotechnology

Tirzepatide

Finnrick tested 4 samples of Tirzepatide (GLP-1 and GIP agonist) from Anlv Biotechnology between 31 Aug 2025 and 7 Jan 2026. Test scores average over 6, no score below 5, and at least 2 tests warrant a tentative Finnrick Rating of B (Good).

Finnrick Rating™
Tentative Rating
Anlv Biotechnology
Tirzepatide
Tested 4 Samples
Last test 7 Jan 2026

Take Action

Researcher

Request Full Data Access to the Finnrick database of peptide tests.

Free peptide testing

Mail in a sample (US only) to get confidence for the specific vials you have, and contribute to identifying unsafe supply chains, so other people can avoid risky and costly mistakes.

All Tirzepatide tests from Anlv Biotechnology

Samples are tested in commercial labs

Tests Count

4

Scores

AVG7.5MIN5.8MAX10.0

Last

7 Jan 2026

First

31 Aug 2025
Quantity
Test DateCertificate
Test Score
LabelTestedDifferencePurityBatch IDContainerTested AtSent By
7 Jan 2026View6.140mg44.3mg+10.8%99.80%(no batch ID)No Label / Silver Crimp / Green CapLab GPublic
29 Dec 2025View10.010mg9.85mg-1.5%99.95%September 2025No Label / Silver Crimp / Yellow CapLab EPublic
23 Oct 2025View5.860mg62.3mg+3.8%98.81%(no batch ID)No Label / Copper Crimp / Clear Cap Lab EPublic
31 Aug 2025View8.020mg19.4mg-3.0%99.95%(no batch ID)No Label / Silver Crimp / Violet CapLab EPublic